NanoString Technologies Inc (NSTG)

18.40
NASDAQ : Health Care
Prev Close 18.21
Day Low/High 17.93 / 18.58
52 Wk Low/High 11.89 / 23.45
Avg Volume 157.00K
Exchange NASDAQ
Shares Outstanding 21.69M
Market Cap 394.98M
EPS -2.30
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

NanoString Technologies is Now Oversold (NSTG)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Commit To Buy NanoString Technologies At $17.50, Earn 14.7% Annualized Using Options

Investors eyeing a purchase of NanoString Technologies Inc shares, but cautious about paying the going market price of $19.38/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the October put at the $17.50 strike, which has a bid at the time of this writing of $1.35.

Digital Spatial Profiling Technology Enables Quantitative Protein Profiling In FFPE Tissue Providing Detailed Molecular Characterization Of Immune Response To Tumors

The Yale School of Medicine Presents Validation of NanoString's Novel Digital Spatial Profiling Technology by Quantitative Immunofluorescence Technology at 2017 American Association for Cancer Research

NanoString Launches Multiple New Products At AACR 2017 To Advance Precision Oncology Research

New Offerings Include nCounter Platform Enhancements as Well as New Panels That Expand NanoString's Footprint in Immuno-oncology and 3D Biology Research

NanoString Highlights A Record Number Of NCounter-Based Research Abstracts In Precision Oncology And Predictive Biomarkers At The 2017 American Association Of Cancer Research (AACR) Annual Meeting

More than 45 Abstracts Demonstrate the Unique Capabilities of the nCounter Analysis System for Disease Characterization in Cancer Research and Immuno-Oncology

NanoString Launches New PlexSet Technology As An Alternative To QPCR For Multiplexed High-Throughput Gene Expression Studies

PlexSet's Simple Workflow Enables High-Plex Expression Analysis and Reduces Hands-on Time as Compared to qPCR

NanoString Technologies Releases Fourth Quarter And Full Year 2016 Operating Results And Provides 2017 Outlook

Highlights for 2016 Include 38% Revenue Growth, Two New Major Biopharma Diagnostic Collaborations and Substantial Progress on Pipeline of New Products and Technologies

The Novartis Institutes For BioMedical Research And NanoString Technologies Demonstrate A Novel Approach For High-Plex, Spatial Profiling Of Proteins Using NCounter-Based Digital Quantification At 2017 ASCO-SITC Clinical Immuno-Oncology Symposium

Digital Spatial Profiling Technology Enables Spatially-Resolved, Quantitative Protein Profiling in FFPE Tissue Providing Detailed Molecular Characterization of Tumors

Oversold Conditions For NanoString Technologies (NSTG)

Oversold Conditions For NanoString Technologies (NSTG)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Biotech Premarket Movers: ILMN, NSTG, KITE

Biotech Premarket Movers: ILMN, NSTG, KITE

Illumina, NanoString Technologies and Kite Pharma are among the premarket movers in biotech.

Commit To Purchase NanoString Technologies At $20, Earn 20.9% Annualized Using Options

Commit To Purchase NanoString Technologies At $20, Earn 20.9% Annualized Using Options

Investors eyeing a purchase of NanoString Technologies Inc shares, but cautious about paying the going market price of $22.87/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the April put at the $20 strike, which has a bid at the time of this writing of $1.20.

The Scientist Magazine Names NanoString Technologies NCounter Vantage 3D Panels A Top 10 Innovation Of 2016

The Scientist Magazine Names NanoString Technologies NCounter Vantage 3D Panels A Top 10 Innovation Of 2016

Assay portfolio enables simultaneous analysis of DNA, RNA, and protein for cancer research

NanoString Technologies Highlights Advances In Precision Oncology At The 58th Annual Meeting Of The American Society Of Hematology

NanoString Technologies Highlights Advances In Precision Oncology At The 58th Annual Meeting Of The American Society Of Hematology

Abstracts Demonstrate the Value of the nCounter Platform for Disease Characterization, Translational Research and Diagnostic Applications in Hematology

NanoString Launches Technology Access Program (TAP) For Transformative Platform For High-Plex Digital Spatial Profiling

NanoString Launches Technology Access Program (TAP) For Transformative Platform For High-Plex Digital Spatial Profiling

nCounter-based system enables multiplex analysis of proteins and RNA in spatial context from Formalin-Fixed, Paraffin-Embedded (FFPE) samples

NanoString Technologies Releases Operating Results For Third Quarter Of 2016

NanoString Technologies Releases Operating Results For Third Quarter Of 2016

Revenue Growth of 53% Year-Over-Year Driven by Increased nCounter SPRINT Demand and Strong Commercial Execution